A Study to Detect and Candida auris


About this study

The purpose of this study is to develop a test that can be used routinely to detect and identify Candida auris from surveillance skin swabs.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

Patients admitted to Saint Mary’s Hospital or Methodist Hospital who have one of the following

  • Reported travel or residence outside of the United States in the last 6 months;
  • Report an address in a State/zip code where C. auris transmission has been reported;
  • Report an address in a country where C. auris transmission has been reported.

Exclusion Criteria:

  • Patient is in Observation on any unit.
  • Patient has tested negative in the past six months.
  • Patient is no longer hospitalized (has been discharged).
  • Patient refuses verbal assent.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nancy Wengenack, Ph.D.

Open for enrollment

Contact information:

Mohamed Ibrahim



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer